Go Pro
NASDAQ:OXBR

Oxbridge Re Q2 2026 Earnings Report

Oxbridge Re logo
$1.57 +0.05 (+3.29%)
Closing price 07/24/2026 03:54 PM Eastern
Extended Trading
$1.61 +0.04 (+2.80%)
As of 07/24/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oxbridge Re EPS Results

Actual EPS
N/A
Consensus EPS
$0.04
Beat/Miss
N/A
One Year Ago EPS
N/A

Oxbridge Re Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.10 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Oxbridge Re Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Thursday, August 13, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

Oxbridge Re Earnings Headlines

Oxbridge Re Holdings Ltd OXBR
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
See More Oxbridge Re Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Oxbridge Re? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oxbridge Re and other key companies, straight to your email.

About Oxbridge Re

Oxbridge Re (NASDAQ:OXBR) (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents. Oxbridge Re works closely with insurers to structure agreements that align risk retention levels, collateral requirements, and profit-sharing mechanics. These arrangements often feature customized features such as experience refunds, corridor enhancements, and risk corridors, providing clients with flexibility in managing long-term liabilities.

Oxbridge Re serves a diversified client base across North America, focusing primarily on life, annuity, and disability insurance portfolios. Its underwriting team brings experience in actuarial modeling, financial analysis, and regulatory compliance, supporting transactions that span single-life, group life, living benefits, and specialized guarantee products. While relatively new to the public markets, Oxbridge Re has built strategic alliances with financial institutions and reinsurers to broaden its capital resources and co‐reinsurance capabilities.

Governed by a board with backgrounds in insurance operations, capital markets, and risk management, Oxbridge Re emphasizes disciplined underwriting standards and capital-efficient structuring. The company aims to differentiate itself through innovative deal design and responsive client service, positioning its platform to address evolving regulatory requirements and competitive pressures within the reinsurance industry.

View Oxbridge Re Profile